ALPHA TEKNOVA, INC. Proceeds from Long-Term Debt Issued
ALPHA TEKNOVA, INC. (TKNO) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2024-03-27
- ALPHA TEKNOVA, INC. proceeds from issuance of long-term debt for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- ALPHA TEKNOVA, INC. proceeds from issuance of long-term debt for the quarter ending 2023-09-30 was $0.00.
- ALPHA TEKNOVA, INC. proceeds from issuance of long-term debt for the quarter ending 2022-12-31 was $5.00M.
- ALPHA TEKNOVA, INC. proceeds from issuance of long-term debt for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- ALPHA TEKNOVA, INC. proceeds from issuance of long-term debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- ALPHA TEKNOVA, INC. proceeds from issuance of long-term debt for fiscal 2022 was $10.13M, a 14.75% decline from fiscal 2021.
- ALPHA TEKNOVA, INC. proceeds from issuance of long-term debt for fiscal 2021 was $11.89M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $0.00 derived: sum of 2 quarters · filed 2024-03-27 | $0.00 10-K · filed 2024-03-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 | |||
| 2022-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $5.00M derived: sum of 2 quarters · filed 2024-03-27 | $10.13M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $5.13M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $5.13M 10-Q · filed 2023-08-11 | |||
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $11.89M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.00K derived: sum of 2 quarters · filed 2022-11-14 | $11.89M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $11.89M 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $11.89M 10-Q · filed 2022-05-12 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |